CBU
EW icon

CIBC Bank USA’s Edwards Lifesciences EW Stock Holding History

CIBC Bank USA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$292K Buy
3,762
+228
+6% +$17.8K 0.04% 233
2019
Q3 		$259K Buy
+3,534
New +$248K 0.04% 239

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CIBC Bank USA's EW Position: Q4 2019 in Review

CIBC Bank USA increased its Edwards Lifesciences (EW) stake by 6.5% in Q4 2019, buying an estimated $17.8K and bringing the position to 3,762 shares worth $292K. The position accounts for 0.04% of the portfolio, ranked #233.

CIBC Bank USA first reported a position in EW in Q3 2019 and has held it in 2 quarters since. 1,092 funds tracked by Wall St. Rank hold EW as of Q4 2019.

  • CIBC Bank USA held 3,762 shares of Edwards Lifesciences worth $292K as of Q4 2019.
  • CIBC Bank USA bought 228 Edwards Lifesciences shares in Q4 2019, an estimated $17.8K.
  • Edwards Lifesciences made up 0.04% of CIBC Bank USA's portfolio in Q4 2019, its #233 holding.
  • CIBC Bank USA first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 2 quarters since.
  • 1,092 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.